FR2973706A1 - Phytoconcentrated composition, useful as antispasmodic relaxant and muscular comfort to e.g. enhance relaxation of painfully contracted muscle tissue, comprises e.g. Cannabis sativa and an excipient comprising e.g. castor oil - Google Patents
Phytoconcentrated composition, useful as antispasmodic relaxant and muscular comfort to e.g. enhance relaxation of painfully contracted muscle tissue, comprises e.g. Cannabis sativa and an excipient comprising e.g. castor oil Download PDFInfo
- Publication number
- FR2973706A1 FR2973706A1 FR1101030A FR1101030A FR2973706A1 FR 2973706 A1 FR2973706 A1 FR 2973706A1 FR 1101030 A FR1101030 A FR 1101030A FR 1101030 A FR1101030 A FR 1101030A FR 2973706 A1 FR2973706 A1 FR 2973706A1
- Authority
- FR
- France
- Prior art keywords
- lavandula
- antispasmodic
- angustifolia
- oil
- essential
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
La présente invention concerne la fabrication d'un Phyto- concentré huileux à usage externe destiné à améliorer le relâchement des tissus musculaires contractés et améliorer la circulation des muscles spasmés et douloureux et à supprimer la douleur. Le traitement des douleurs dues aux spasmes des muscles contractés se pratique traditionnellement sous la forme de pommades ou de crèmes topiques transcutanées constituées de produits de synthèse chimique qui peuvent être ajoutés à des produits naturels mixés à un excipient synthétique très souvent. Le même objectif est pris en considération par des formules naturelles associées ou non à des excipients chimiques ou naturels mais qui ne développent pas l'efficacité immédiate de la résolution du spasme douloureux du muscle entrainants des conséquences inflammatoires des tissus voisins comme ligament tendon articulation. Le concentré réalisé selon l'invention permet de remédier à ces inconvénients, et d'optimiser les performances des actifs spécifiques du muscle. Il a été crée autour du triptyque pathologique, douleur, spasme, inflammation, qui caractérise tous les problèmes musculosquelettiques. Nous répondrons aux trois critères à résoudre par trois solutions naturelles: Un antidouleur couplé à un antispasmodique et à un anti-inflammatoire. Tous sont naturels et agissent dans une synergie d'action réciproque qui renforce la qualité des actifs entre eux. Rappelons que les huiles essentielles sont constituées de diverse substances secrétées par les cellules végétales, qu'elles véhiculent l'information et l'énergie de la plante. Le mélange des extraits de plantes contenus dans le concentré développe des propriétés anti-inflammatoires naturelles avec la levée des spasmes artériolaires, des propriétés antispasmodiques, antalgiques, analgésiques, anesthésiques. Elles ont une perméabilité percutanée puissante pour traiter les fortes douleurs, tendino- musculaires et ostéo- articulaire. On peut ajouter des esters et éthers qui calment le spasme et lèvent donc la douleur conséquente. L'originalité du brevet est d'utiliser l'huile essentielle de Cannabis Salive par son actif principal, le Cannabidiole alors que l'autre substance hallucinogène (T H C) est absente ; L'huile essentielle de Cannabis Saliva a des vertus anti-inflammatoires par la présence de béta -caryophyllène avec, des effets, relaxant sur les muscles, sédatifs sur les douleurs rhumatismales aigues et chroniques. Le Cannabis Saliva permettra une relaxation du muscle par son effet sédatif, myorelaxant et, anti-inflammatoire. La solution au problème posé par le triptyque pathologique est résolue par l'usage de cet extrait naturel, traditionnel et ancien, qui résout à lui seul le problème posé. Des règles naturelles caractérisent l'action du totem phytothérapeutique. Il n'est pas que la somme des constituants ou chacun développe mieux ses vertus en la présence des autres, ou chaque constituant agit qualitativement et quantitativement sur tous les autres et sur l'ensemble pour donner un entier unique. Les informations naturelles aromatiques anti- douleur, anti- spasmodique et anti-inflammatoire seront superposées et renforcées en synergie par des informations qualitatives identiques des autres actifs naturels, qui ajouteront une efficacité synergique aux informations pharmacocinétiques du Cannabis Saliva . D'autres actifs comme le Laurier Noble renforcera le Cannabis Sativa sédatif et myorelaxant, par son action antalgique anesthésique et antispasmodique, spécifique des crampes et des douleurs des muscles. D'autres actifs comme le Rosmarinus off.camph, connu pour son action neuro musculaire, renforcera l'action myorelaxante du Cannabidiol (du Cannabis Sativa ) par son action antispasmodique, et décontracturante, permettant une décontraction musculaire sédative. L' Harpagophytum Procubens, anti-inflammatoire, cortisonne litre , renforce le caractère anti- inflammatoire de l'huile essentielle de Cannabis. Il agit sur la douleur et l'inflammation, améliore nettement la mobilité des articulations, renforcera l'action antalgique et antispasmodique du Cannabis, pour atténuer les douleurs rhumatismales, articulaires et soulager les tendinites. L'ensemble du totem maintient la mobilité des mouvements des membres, la souplesse des tendons et des muscles . The present invention relates to the manufacture of an oily phyto-concentrate for external use intended to improve the relaxation of contracted muscle tissue and improve the circulation of spasmatic and painful muscles and to suppress pain. The treatment of contractile muscle spasm pain has traditionally been in the form of transcutaneous topical ointments or creams consisting of synthetic chemicals that can be added to natural products mixed with a synthetic excipient very often. The same objective is taken into consideration by natural formulas associated or not with chemical or natural excipients but which do not develop the immediate effectiveness of the resolution of the painful spasm of the muscle causing inflammatory consequences of the neighboring tissues like ligament tendon articulation. The concentrate produced according to the invention overcomes these drawbacks, and optimizes the performance of specific muscle assets. It was created around the pathological triptych, pain, spasm, inflammation, which characterizes all the musculoskeletal problems. We will answer the three criteria to be solved by three natural solutions: A pain reliever coupled with an antispasmodic and an anti-inflammatory. All are natural and act in a synergy of interaction that enhances the quality of the assets between them. Let's remember that the essential oils consist of several substances secreted by the plant cells, that they convey the information and the energy of the plant. The mixture of plant extracts contained in the concentrate develops natural anti-inflammatory properties with the lifting of arteriolar spasms, antispasmodic, analgesic, analgesic and anesthetic properties. They have a powerful percutaneous permeability to treat severe pain, tendon-muscular and osteo-articular. Esters and ethers can be added to calm the spasm and so raise the pain. The originality of the patent is to use the essential oil of Cannabis Saliva by its main active ingredient, Cannabidiole while the other hallucinogenic substance (T H C) is absent; The essential oil of Cannabis Saliva has anti-inflammatory properties by the presence of beta-caryophyllene with, effects, relaxing on the muscles, sedatives on acute and chronic rheumatic pains. The Cannabis Saliva will allow a relaxation of the muscle by its sedative, myorelaxant and anti-inflammatory effect. The solution to the problem posed by the pathological triptych is solved by the use of this natural extract, traditional and old, which solves the problem alone. Natural rules characterize the action of the phytotherapeutic totem. It is not that the sum of the constituents or each one develops its virtues better in the presence of others, or each constituent acts qualitatively and quantitatively on all the others and on the whole to give a unique whole. The natural aromatic anti-pain, anti-spasmodic and anti-inflammatory information will be superimposed and synergistically enhanced by identical qualitative information from other natural actives, which will add synergistic efficacy to the pharmacokinetic information of Cannabis Saliva. Other active ingredients such as Laurel Noble will strengthen sedative and myorelaxant Cannabis Sativa by its anesthetic and antispasmodic analgesic action, which is specific to muscle cramps and pains. Other active ingredients, such as Rosmarinus off.camph, known for its neuro-muscular action, will strengthen the muscle-relaxant action of Cannabidiol (Cannabis Sativa) by its antispasmodic and decontracting action, allowing sedative muscle relaxation. Harpagophytum Procubens, anti-inflammatory, cortisone liter, reinforces the anti-inflammatory character of the essential oil of Cannabis. It acts on pain and inflammation, significantly improves the mobility of the joints, strengthen the analgesic and antispasmodic action of Cannabis, to reduce rheumatic and articular pain and relieve tendinitis. The entire totem maintains mobility of limb movements, tendon flexibility and muscle flexibility.
La présente Composition, huileuse essentielle à usage externe est destinée à diminuer et ou faire disparaitre une tension musculaire d'origine mécanique et ou neuro-émotionnelle, et à prévenir les contractures musculaires squelettiques et les douleurs qu'elles entrainent. Par la même il diminue les douleurs articulaires inflammatoires et chroniques ainsi que les douleurs de la fybromyalgie. On provoque en topique l'absorption du phytoconcentré à effet 20 vasoactif orthogonal par la peau située sur la zone ressentie douloureuse ou sur le point de détente musculaire spécifique du muscle concerné. La peau véritable réservoir naturel distribue comme le fait une poche de perfusion la composition vers les vaisseaux sanguins hypodermiques dilatés par les actifs. La microvascularisation sous cutanée des espaces conjonctifs et aponévrotiques musculaires se dilate. Par conséquence les micro-vaisseaux du muscle squelettique et la microvascularisation articulaire et péri-articulaire se dilatent. La composition concentrée huileuse essentielle perfuse maintenant le muscle avec un effet décontracturant, antalgique, antispasmodique, et agit sur l'inflammation tendineuse, musculo-aponévrotique, et capsuloligamentaire. Il améliore nettement la mobilité articulaire diminue la douleur musculaire et les algies articulaires. L'invention à titre d'exemple sera décrite en précisant sa composition et son mode de préparation. Composition Phytoconcentrée essentielle décontracturante antispasmodique et de confort musculaire, qui comprend : du Cannabis Sativa aux effets antalgiques, antispasmodiques et anti-inflammatoire, un anti-inflammatoire consistant en de l'extait d'Harpagophytum Procubens sous la forme de d'une teinture mère ,choisi parmi les anti-inflammatoires suivants : Copaifera martii Hayne, Coriandrum sativum , Cuminum 25 30 35 cyminum Sapinette noire - Picea mariana ,Artemisia dracunculus L. ,Eucalyptus citriodora, Eucalyptus radiata ,Ferula galbaniflua Geranium rosat ou "odorant" - Pelargonium asperum, Helichrysum gymnocephalum , Innula graveolens, Cedrelopsis graveii ,Lavande fine - Lavandula angustifolia Mill.. ssP. Angustifolia, Maillette - Lavandula angustifolia, Lavandula latifolia Medicus cineolifera Lavandula angustifolia Lavandula angustifolia , Lavandula stoechas L. Lavendula angustifolia P. Miller x Lavandula latifolia Linnaeus , Lavandula burnatii super Ledum groenlandicum , Cymbopogon flexuosus, Litsea cubeba, Litsea citrata Lippia citriodora , Zanthoxylum armatum , Zanthoxylum armatum , Tanacetum annuum Citrus hystrix DC, Citrus aurantium L. ssp. amara var. pumilia, Citrus aurantium amaraLitsea cubeba Persoon, Litsea citrate Pogostemon cablin , Nardostachys jatamansi Mentha piperita, Mentha citrata L. , Melissa officinalis ,Litsea cubeba, Litsea citrata ,Nepeta cataria L. un antispasmodique choisi parmi les antispasmodiques suivants : macération des fleurs de Calendula officinalis, Chamaemelum nobile, Foeniculum vulgare ssp. capillaceum var. dulce - Griffes de Girofle Syzygium aromaticum - Eugenia caryophyllus (Sprengel) Bullock et S. Harrison ,Clous de Girofle - Syzygium aromaticum - Eugenia caryophyllus (Sprengel) Bullock et S. Harrison, Helichrysum gymnocephalum Cedrelopsis graveii, Laurus nobilis , Lavandula angustifolia Mill ssP., Angustifolia, Maillette Lavandula angustifolia, Lavendula angustifolia P., Miller x Lavandula latifolia Linnaeus Lavandula burnati Briquet ,Mentha arvensis L. Mentha piperita. de préférence le Romarins off.camph, un antalgique choisi parmi les antalgiques suivants : Macération des fleurs de Calendula officinalis, Chamaemelum nobile, Foeniculum vulgare ssp. capillaceum var. dulce - Griffes de Girofle Syzygium aromaticum - Eugenia caryophyllus (Sprengel) Bullock et S. Harrison ,Clous de Girofle - Syzygium aromaticum - Eugenia caryophyllus (Sprengel) Bullock et S. Harrison, Helichrysum gymnocephalum Cedrelopsis graveii, Laurus nobilis , Lavandula angustifolia Mill. ssP., Angustifolia, Maillette Lavandula angustifolia, Lavendula angustifolia P., Miller x Lavandula latifolia Linnaeus Lavandula burnati Briquet ,Mentha arvensis L.Mentha piperita, de préférence le Laurius Nobilis , et un excipient consistant au moins en de l' huile végétale de ricin. Elle contient un mélange d'huiles essentielles de Cannabis Sativa, de Rosmarinus off.camph, et de Laurius Nobilis , d'une teinture mère d'Harpagophytum Procubens, de le tout mixé à un excipient consistant au moins en de 1' huile végétale de ricin sous la forme de la préparation pharmaceutique appelée Ricinion, mélangée à une huile végétale excipiente choisie parmi les huiles végétales végétales mixables aux huile essentielles, de préférence 1' huile végétale de pépin de raisin ou d'amande douce. La composition comprend, un mélange liquide contenant des plantes broyées sous la forme d'huiles essentielles, du type, Cannabis Sativa dans une proportion de 1ml à 5ml en volume, Rosmarinus off. camph., dans une proportion de 1 ml à 5ml en volume, Laurus nobilis . dans une proportion de 1ml à 5m1 en volume, d'un extrait titré d'Harpagophytum dans une proportion de 1mi à 35m1 en volume , sous la forme d'une teinture mère qui est aspirée par la peau, au moyen des huiles essentielles véritables transporteurs transcutanés qui les accompagnent et les encadrent , pour les diriger vers les tissus profonds et musculo aponévrotiques, de telle sorte que ses actifs moléculaires anti inflammatoires se mélangent, et sont optimisés en synergie avec les actifs anti- inflammatoires du Cannabis, et sont mixés dans une huile végétale de Ricinion de 3m1 à 15 ml, et de Pépin de Raisin ou d' Amande douce en quantité suffisante pour .La composition décrite est obtenue au moyen d'un mélange liquide contenant des huile essentielles du type, Rosmarinus off. camph. dans une proportion de 13,3 % en volume, Laurus nobilis. dans une proportion de 6,66% en volume, Canabis Sativa dans une proportion de 6,66% en volume ,d' une teinture mère d'Harpagophytum dans une proportion de 20% en volume, mélangées dans une huile végétale de ricin sous la forme de la préparation pharmaceutique appelée Ricinion, de 33,26 % en volume, et de pépin de raisin ou d' Amande douce en quantité suffisante pour, qui sont aspirées par la peau au moyen des huiles essentielles qui les entrainent vers les tissus profonds. Le Procédé de préparation de la Composition consiste à mélanger à froid les huiles essentielles à base de Rosmarinus off.camph , de Laurius Nobilis , Cannabis Sativa, la teinture mère d'Harpagophytum Procubens et les huiles végétales excipientes de Ricin sous la forme de la préparation pharmaceutique appelée Ricinion, de manière non limitative une huile végétale, choisie parmi toutes les huiles végétales mélangeables aux huiles essentielles, de préférence de l'huile de pépin de raisin ou de l'huile d'amande douce. The present Oily Essential Composition for external use is intended to reduce and / or eliminate muscle tension of mechanical origin and / or neuro-emotional, and prevent skeletal muscle contractures and pain they cause. At the same time it reduces the inflammatory and chronic articular pains as well as the pains of the fybromyalgia. The topical absorption of orthogonal vasoactive phytoconcentrate is caused by the skin located on the painful area felt or on the point of muscle relaxation specific to the muscle concerned. The true natural reservoir skin distributes as an infusion bag the composition to the hypodermic blood vessels dilated by the assets. The subcutaneous microvasculature of the connective and muscular fascial spaces expands. As a consequence, the micro-vessels of the skeletal muscle and the articular and peri-articular microvasculature dilate. The concentrated oily concentrate composition now infuses the muscle with a descontracturant effect, analgesic, antispasmodic, and acts on tendon inflammation, musculoaponeurotic, and capsuloligament. It significantly improves joint mobility reduces muscle pain and joint pain. The invention by way of example will be described by specifying its composition and its method of preparation. Phytoconcentric essential decontracting antispasmodic composition and muscle comfort, which includes: Cannabis Sativa analgesic effect, antispasmodic and anti-inflammatory, an anti-inflammatory consisting of extait Harpagophytum Procubens in the form of a mother tincture, selected from the following anti-inflammatory agents: Copaifera martii Hayne, Coriandrum sativum, Cuminum 25 30 35 cyminum Black spruce - Picea mariana, Artemisia dracunculus L., Eucalyptus citriodora, Eucalyptus radiata, Ferula galbaniflua Geranium rosat or "fragrant" - Pelargonium asperum, Helichrysum Gymnocephalum, Innula graveolens, Cedrelopsis graveii, Fine Lavender - Lavandula angustifolia Mill .. ssP. Angustifolia, Millet - Lavandula angustifolia, Lavandula latifolia Medicus cineolifera Lavandula angustifolia Lavandula angustifolia, Lavandula stoechas L. Lavendula angustifolia P. Miller x Lavandula latifolia Linnaeus, Lavandula burnatii super Ledum greenlandicum, Cymbopogon flexuosus, Litsea cubeba, Cappuccino Lippia citriodora, Zanthoxylum armatum, Zanthoxylum armatum, Tanacetum annuum Citrus hystrix DC, Citrus aurantium L. ssp. amara var. pumilia, Citrus aurantium amaraLitsea cubeba Persoon, Litsea citrate Pogostemon cablin, Nardostachys jatamansi Mentha piperita, Mentha citrata L., Melissa officinalis, Litsea cubeba, Litsea citrata, Nepeta cataria L. an antispasmodic selected from the following antispasmodics: maceration of the flowers of Calendula officinalis , Chamaemelum nobile, Foeniculum vulgare ssp. capillaceum var. dulce - Cloves of Clove Syzygium aromaticum - Eugenia caryophyllus (Sprengel) Bullock and S. Harrison, Cloves - Syzygium aromaticum - Eugenia caryophyllus (Sprengel) Bullock and S. Harrison, Helichrysum gymnocephalum Cedrelopsis graveii, Laurus nobilis, Lavandula angustifolia Mill ssP. , Angustifolia, Lavandula angustifolia, Lavendula angustifolia, Miller x Lavandula latifolia Linnaeus Lavandula burnati Lighter, Mentha arvensis L. Mentha piperita. preferably the Romarins off.camph, an analgesic chosen from the following analgesics: Maceration of the flowers of Calendula officinalis, Chamaemelum nobile, Foeniculum vulgare ssp. capillaceum var. dulce - Cloves of Clove Syzygium aromaticum - Eugenia caryophyllus (Sprengel) Bullock and S. Harrison, Cloves - Syzygium aromaticum - Eugenia caryophyllus (Sprengel) Bullock and S. Harrison, Helichrysum gymnocephalum Cedrelopsis graveii, Laurus nobilis, Lavandula angustifolia Mill. ssP., Angustifolia, Lavandula angustifolia, Lavendula angustifolia, Miller x Lavandula latifolia Linnaeus Lavandula burnati Lighter, Mentha arvensis L.Mentha piperita, preferably Laurius Nobilis, and an excipient consisting of at least castor oil . It contains a blend of essential oils of Cannabis Sativa, Rosmarinus off.camph, and Laurius Nobilis, a mother tincture of Harpagophytum Procubens, all mixed with an excipient consisting of at least vegetable oil. ricin in the form of the pharmaceutical preparation called Ricinion, mixed with an excipient vegetable oil chosen from vegetable vegetable oils which can be mixed with essential oils, preferably vegetable oil of grape seed or sweet almond. The composition comprises a liquid mixture containing crushed plants in the form of essential oils, of the type, Cannabis Sativa in a proportion of 1ml to 5ml by volume, Rosmarinus off. camph., in a proportion of 1 ml to 5 ml by volume, Laurus nobilis. in a proportion of 1ml to 5m1 by volume, of a titrated extract of Harpagophytum in a proportion of 1mi to 35m1 by volume, in the form of a mother tincture which is sucked by the skin, using true essential oils transporters transcutaneous that accompany and frame them, to direct them to the deep tissues and musculo aponeurotic, so that its anti-inflammatory molecular assets are mixed, and are optimized in synergy with the anti-inflammatory assets of Cannabis, and are mixed in a vegetable oil of Ricinion of 3m1 to 15 ml, and Grape seed or sweet almond in sufficient quantity for .The composition described is obtained by means of a liquid mixture containing essential oils of the type, Rosmarinus off. Camph. in a proportion of 13.3% by volume, Laurus nobilis. in a proportion of 6.66% by volume, Canabis Sativa in a proportion of 6.66% by volume, of a mother tincture of Harpagophytum in a proportion of 20% by volume, mixed in a vegetable oil of castor oil under the form of the pharmaceutical preparation called Ricinion, of 33.26% by volume, and grape seed or sweet almond in sufficient quantity for, which are sucked by the skin by means of the essential oils which lead them towards the deep tissues. The process for the preparation of the composition consists in cold mixing the essential oils based on Rosmarinus off.camph, Laurius Nobilis, Cannabis Sativa, the mother tincture of Harpagophytum Procubens and the excipient vegetable oils of Ricin in the form of the preparation pharmaceutical called Ricinion, in a nonlimiting manner a vegetable oil, chosen from all vegetable oils mixed with essential oils, preferably grape seed oil or sweet almond oil.
Le Procédé de conservation de la composition est maintenu à température ordinaire entre cinq et vingt sept degrés. , et à pression atmosphérique sans ajouts chimiques adjuvants. The method for preserving the composition is maintained at an ordinary temperature of between five and twenty-seven degrees. , and at atmospheric pressure without adjuvant chemical additions.
35 35
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR1101030A FR2973706B1 (en) | 2011-04-06 | 2011-04-06 | ESSENTIAL PHYTO-CONCENTRATE COMPOSITION ANTISPASMODIC DISCOVERY AND MUSCLE COMFORT |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR1101030A FR2973706B1 (en) | 2011-04-06 | 2011-04-06 | ESSENTIAL PHYTO-CONCENTRATE COMPOSITION ANTISPASMODIC DISCOVERY AND MUSCLE COMFORT |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2973706A1 true FR2973706A1 (en) | 2012-10-12 |
FR2973706B1 FR2973706B1 (en) | 2016-05-20 |
Family
ID=44549505
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR1101030A Expired - Fee Related FR2973706B1 (en) | 2011-04-06 | 2011-04-06 | ESSENTIAL PHYTO-CONCENTRATE COMPOSITION ANTISPASMODIC DISCOVERY AND MUSCLE COMFORT |
Country Status (1)
Country | Link |
---|---|
FR (1) | FR2973706B1 (en) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2464692A1 (en) * | 2014-01-27 | 2014-06-03 | Cnce Innovacion, S.L. | Composition for the improvement of female sexual response (Machine-translation by Google Translate, not legally binding) |
ES2536121A1 (en) * | 2013-11-19 | 2015-05-20 | Francisca CORTÉS DÍAZ | Natural lotion for the preparation of oils and creams (Machine-translation by Google Translate, not legally binding) |
WO2017178937A1 (en) * | 2016-04-13 | 2017-10-19 | Uab Satimed | The oleo gel composition and delivery system with active compounds from cannabis sativa and mentha arvensis for reduction of inflammation and pain in deep tissues |
WO2019073127A2 (en) | 2017-10-12 | 2019-04-18 | Nguyen Gerard | Phyto-concentrated composition and uses thereof |
FR3072290A1 (en) * | 2017-10-16 | 2019-04-19 | Genialis Biotech | OIL-IN-WATER EMULSION BASED ON ESSENTIAL OILS AND FORMULATED WITHOUT SURFACTANTS |
US10933013B1 (en) | 2016-04-25 | 2021-03-02 | Ethan D Dean | Oral hygiene compositions containing extract of cannabis plant |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU3548684A (en) * | 1984-11-16 | 1986-05-22 | Yubo, B. | Ointment |
US6146639A (en) * | 1999-07-26 | 2000-11-14 | Merich Nick | Arthritis, muscle pain, and dry skin remedy |
WO2002069993A1 (en) * | 2001-03-06 | 2002-09-12 | Forschungsinstitut Hiscia Verein Für Krebsforschung | Pharmaceutical composition made of cannabis extracts |
US6541045B1 (en) * | 2002-01-04 | 2003-04-01 | Nutraceutical Corporation | Herbal composition and method for combating inflammation |
CN1772043A (en) * | 2003-07-30 | 2006-05-17 | 俞巧萍 | Medicine recipe for health massage to relax the muscles and joints and eliminate pain |
US20080057117A1 (en) * | 2002-02-15 | 2008-03-06 | Forschungs Institut Miscia Verenfur Krebsforschung | Pharmaceutical composition made up of cannibus extracts |
US20100261663A1 (en) * | 2009-04-08 | 2010-10-14 | Restorative Remedies | Compositions Containing Harpagoside and Paeoniflorin and Methods for Treatment of Conditions Associated with Pain, Inflammation, Arthritis and Symptoms Thereof |
-
2011
- 2011-04-06 FR FR1101030A patent/FR2973706B1/en not_active Expired - Fee Related
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU3548684A (en) * | 1984-11-16 | 1986-05-22 | Yubo, B. | Ointment |
US6146639A (en) * | 1999-07-26 | 2000-11-14 | Merich Nick | Arthritis, muscle pain, and dry skin remedy |
WO2002069993A1 (en) * | 2001-03-06 | 2002-09-12 | Forschungsinstitut Hiscia Verein Für Krebsforschung | Pharmaceutical composition made of cannabis extracts |
US6541045B1 (en) * | 2002-01-04 | 2003-04-01 | Nutraceutical Corporation | Herbal composition and method for combating inflammation |
US20080057117A1 (en) * | 2002-02-15 | 2008-03-06 | Forschungs Institut Miscia Verenfur Krebsforschung | Pharmaceutical composition made up of cannibus extracts |
CN1772043A (en) * | 2003-07-30 | 2006-05-17 | 俞巧萍 | Medicine recipe for health massage to relax the muscles and joints and eliminate pain |
US20100261663A1 (en) * | 2009-04-08 | 2010-10-14 | Restorative Remedies | Compositions Containing Harpagoside and Paeoniflorin and Methods for Treatment of Conditions Associated with Pain, Inflammation, Arthritis and Symptoms Thereof |
Non-Patent Citations (3)
Title |
---|
DATABASE TCM [online] SIPO; 17 May 2006 (2006-05-17), XP002662369, Database accession no. CN1772043 * |
GÖBEL H ET AL: "[Effects of Harpagophytum procumbens LI 174 (devil's claw) on sensory, motor und vascular muscle reagibility in the treatment of unspecific back pain].", SCHMERZ (BERLIN, GERMANY) FEB 2001 LNKD- PUBMED:11810324, vol. 15, no. 1, February 2001 (2001-02-01), pages 10 - 18, XP002662368, ISSN: 0932-433X * |
WIRTH ET AL: "Use of Herbal Therapies to Relieve Pain: A Review of Efficacy and Adverse Effects", PAIN MANAGEMENT NURSING, W.B. SAUNDERS, vol. 6, no. 4, 1 December 2005 (2005-12-01), pages 145 - 167, XP005198361, ISSN: 1524-9042, DOI: 10.1016/J.PMN.2005.08.003 * |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2536121A1 (en) * | 2013-11-19 | 2015-05-20 | Francisca CORTÉS DÍAZ | Natural lotion for the preparation of oils and creams (Machine-translation by Google Translate, not legally binding) |
ES2464692A1 (en) * | 2014-01-27 | 2014-06-03 | Cnce Innovacion, S.L. | Composition for the improvement of female sexual response (Machine-translation by Google Translate, not legally binding) |
WO2017178937A1 (en) * | 2016-04-13 | 2017-10-19 | Uab Satimed | The oleo gel composition and delivery system with active compounds from cannabis sativa and mentha arvensis for reduction of inflammation and pain in deep tissues |
US10918686B2 (en) | 2016-04-13 | 2021-02-16 | Uab Satimed | Oleo gel composition and delivery system with active compounds from cannabis sativa and mentha arvensis for reduction of inflammation and pain in deep tissues |
US10933013B1 (en) | 2016-04-25 | 2021-03-02 | Ethan D Dean | Oral hygiene compositions containing extract of cannabis plant |
WO2019073127A2 (en) | 2017-10-12 | 2019-04-18 | Nguyen Gerard | Phyto-concentrated composition and uses thereof |
FR3072290A1 (en) * | 2017-10-16 | 2019-04-19 | Genialis Biotech | OIL-IN-WATER EMULSION BASED ON ESSENTIAL OILS AND FORMULATED WITHOUT SURFACTANTS |
FR3072280A1 (en) * | 2017-10-16 | 2019-04-19 | Isabelle Desjardins-Lavisse | OIL-IN-WATER EMULSION BASED ON ESSENTIAL OILS AND FORMULATED WITHOUT SURFACTANTS |
WO2019077258A1 (en) * | 2017-10-16 | 2019-04-25 | Genialis Biotech | Oil-in-water emulsion based on essential oils, and formulated without surfactant |
Also Published As
Publication number | Publication date |
---|---|
FR2973706B1 (en) | 2016-05-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FR2973706A1 (en) | Phytoconcentrated composition, useful as antispasmodic relaxant and muscular comfort to e.g. enhance relaxation of painfully contracted muscle tissue, comprises e.g. Cannabis sativa and an excipient comprising e.g. castor oil | |
US10322155B2 (en) | Topical formulation and uses thereof | |
EP2155222B1 (en) | Extract of trigonella foenum-graecum | |
US20210330638A1 (en) | Nano-penetrative cannabinoid oil blends and compositions and methods of formulation thereof | |
KR101404798B1 (en) | Aroma essence using natural herbs and method of the same | |
Uzbay | Serotonergic anti-depressants and ethanol withdrawal syndrome: a review | |
Appleton | Lavender oil for anxiety and depression | |
JP2021172620A (en) | Oral care agent | |
WO2022159614A1 (en) | Stable organic cannabinoid oil blend formulations | |
Biney et al. | Neuropharmacological effects of an ethanolic fruit extract of Xylopia aethiopica and xylopic acid, a kaurene diterpene isolate, in mice | |
CN108295191A (en) | A kind of acne-removing composition and preparation method thereof inhibiting Propiobacterium | |
KR100399720B1 (en) | Composition containing extract derived from natural products that have growth-inhibition activity against dandruff causing microorganism | |
Denis-Esdras et al. | Ethnobotany study of Loranthaceae, hemiparasitic plants used in traditional medicine by population, in the Sud-Comoé region (Côte d’Ivoire) | |
Kumar et al. | Pharmaco-phylogenetic investigation of Micromeria biflora Benth and Citrus reticulata Blanco | |
CN109562182A (en) | Pharmaceutical preparation comprising cineole and Amoxicillin | |
KR20030074055A (en) | Composition containing extract derived from natural products that have growth-inhibition activity against dandruff causing microorganism | |
DE60018567T2 (en) | USE OF PROPIONAIC BACTERIA FOR THE PREPARATION OF PROPIONIC ACID IN THICK DARM | |
US11717496B2 (en) | Cannabinoid formulation containing active ingredients and carrier for transdermal absorption to treat neuropathy | |
Price | Traditional Use, Research and Properties | |
Axe et al. | The Chemistry of Essential Oils | |
KR100521784B1 (en) | Composition containing extract derived from natural products that have growth-inhibition activity against dandruff causing microorganism | |
Belcheff | A medical intuitive reveals the wonders of Purslane | |
Kamel et al. | Effectiveness of Local Clove Oil Formula on Some Pathogenic Bacteria and Muscle Spasms | |
Wulandari et al. | Potential of Essential Oil as Anti-Dandruff in Scalp Treatment Preparations | |
JPH0687732A (en) | Bathing agent utilizing effect on promoting percutaneous absorption of medicine by essential oil ingredient in extract on cnidii rhizoma |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PLFP | Fee payment |
Year of fee payment: 5 |
|
PLFP | Fee payment |
Year of fee payment: 6 |
|
PLFP | Fee payment |
Year of fee payment: 7 |
|
PLFP | Fee payment |
Year of fee payment: 8 |
|
PLFP | Fee payment |
Year of fee payment: 9 |
|
ST | Notification of lapse |
Effective date: 20201214 |
|
PLFP | Fee payment |
Year of fee payment: 11 |
|
RN | Application for restoration |
Effective date: 20210610 |
|
FC | Decision of inpi director general to approve request for restoration |
Effective date: 20210819 |
|
PLFP | Fee payment |
Year of fee payment: 12 |
|
PLFP | Fee payment |
Year of fee payment: 13 |